Bigfoot Biomedical announced today that it appointed former Insulet executive Matt Rainville as its chief commercial officer.
Rainville’s role includes leading the growth of Milpitas, California-based Bigfoot Biomedical’s fully commercial Bigfoot Unity diabetes management program as the company looks to expand access to its offerings.
Get the full story at our sister site, Drug Delivery Business News.